A compound does not should be shown being a controlled material with the DEA being taken care of being a Schedule I substance for prison prosecution. A managed compound analogue (by way of example, a "designer drug") is actually a substance and that is structurally or pharmacologically much like a Routine I or Timetable II material, especially util